Embecta Corp. (EMBC) is a Healthcare stock trading at $3.13 (as of 2026-06-18), with a market capitalization of $200.53M and a trailing P/E of 1.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Embecta Corp. is a medical device company focused on products and tools for people managing diabetes, including pen needles, syringes, safety devices, and related digital applications. It distributes these offerings through wholesalers and distributors in the United States and internationally.